Reprogramming Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD1 Therapy is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0.165. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 5R01NS118929-04
Reprogramming the Tumor Microenvironment to Improve Immunotherapy of Glioblastoma by Co-Targeting VEGF and Ang2
National Institutes of Health
Grant: 1R01CA247441-01A1
Vascularized tumor explants for drug testing
National Institutes of Health
Grant: 5R01CA260857-03
Multiplexed time domain fluorescence tomography of tumor biomarkers during immunotherapy
National Institutes of Health
Grant: 5R03CA256764-02
Radiation and CSPG4-specifc CAR T cell based combinatorial therapy for the in vivo treatment of TNBC
National Institutes of Health
Grant: 5R01CA259253-02
Improving treatment of HER2+ breast cancer brain metastasis by targeting lipid metabolism
National Institutes of Health
Grant: 4U01CA224348-02
Reprogramming PDAC tumor microenvironment to improve immunotherapy
National Institutes of Health
Grant: 5R01CA208205-03
Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment
National Institutes of Health
Grant: 1P01CA261669-01
Integrating patient-specific clinical and biological factors towards individualizing utilization of proton and photon radiation therapy.
National Institutes of Health
Grant: 1U01CA261842-01
Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistance
National Institutes of Health
Grant: 1K22CA258410-01
Targeting abnormal immunomechanics in the glioblastoma microenvironment to improve therapeutic response
Fields of Study
Keywords
Sustainable Development Goals